149 related articles for article (PubMed ID: 30977389)
1. E-cadherin germline mutations in Māori population.
De Scalzi AM; Bonanni B; Galimberti V; Veronesi P; Pravettoni G; Corso G
Future Oncol; 2019 Apr; 15(12):1291-1294. PubMed ID: 30977389
[No Abstract] [Full Text] [Related]
2. Germline CDH1 mutations are a significant contributor to the high frequency of early-onset diffuse gastric cancer cases in New Zealand Māori.
Hakkaart C; Ellison-Loschmann L; Day R; Sporle A; Koea J; Harawira P; Cheng S; Gray M; Whaanga T; Pearce N; Guilford P
Fam Cancer; 2019 Jan; 18(1):83-90. PubMed ID: 29589180
[TBL] [Abstract][Full Text] [Related]
3. Clinical criteria revision for hereditary lobular breast cancer associated with E-cadherin germline mutations.
Corso G; De Scalzi A; Feroce I; Veronesi P; Bonanni B; Galimberti V
Per Med; 2018 May; 15(3):153-155. PubMed ID: 29745790
[No Abstract] [Full Text] [Related]
4. Germline mutations of the E-cadherin gene (CDH1) in early onset gastric cancer.
Corso G; Roviello F
Semin Oncol; 2020; 47(2-3):125-126. PubMed ID: 32416945
[No Abstract] [Full Text] [Related]
5. E-cadherin germline mutations and risk of gastric cancer.
McColl KE; El-Omar E
Gastroenterology; 2002 Oct; 123(4):1406; author reply 1406-7. PubMed ID: 12360507
[No Abstract] [Full Text] [Related]
6. CDH1/E-cadherin germline mutations in early-onset gastric cancer.
Bacani JT; Soares M; Zwingerman R; di Nicola N; Senz J; Riddell R; Huntsman DG; Gallinger S
J Med Genet; 2006 Nov; 43(11):867-72. PubMed ID: 16801346
[TBL] [Abstract][Full Text] [Related]
7. Gastric cancer: new genetic developments.
Lynch HT; Grady W; Suriano G; Huntsman D
J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
[TBL] [Abstract][Full Text] [Related]
8. Genetic testing by cancer site: stomach.
Chun N; Ford JM
Cancer J; 2012; 18(4):355-63. PubMed ID: 22846738
[TBL] [Abstract][Full Text] [Related]
9. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria.
Brooks-Wilson AR; Kaurah P; Suriano G; Leach S; Senz J; Grehan N; Butterfield YS; Jeyes J; Schinas J; Bacani J; Kelsey M; Ferreira P; MacGillivray B; MacLeod P; Micek M; Ford J; Foulkes W; Australie K; Greenberg C; LaPointe M; Gilpin C; Nikkel S; Gilchrist D; Hughes R; Jackson CE; Monaghan KG; Oliveira MJ; Seruca R; Gallinger S; Caldas C; Huntsman D
J Med Genet; 2004 Jul; 41(7):508-17. PubMed ID: 15235021
[TBL] [Abstract][Full Text] [Related]
10. Cate's Story: Hereditary Diffuse Gastric Cancer.
Rogers M
Clin J Oncol Nurs; 2016 Aug; 20(4):443-5. PubMed ID: 27441520
[TBL] [Abstract][Full Text] [Related]
11. Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literature.
Corso G; Marrelli D; Pascale V; Vindigni C; Roviello F
BMC Cancer; 2012 Jan; 12():8. PubMed ID: 22225527
[TBL] [Abstract][Full Text] [Related]
12. A new mutation of the CDH1 gene in a patient with an aggressive signet-ring cell carcinoma of the stomach.
Caggiari L; Miolo G; Canzonieri V; De Zorzi M; Alessandrini L; Corona G; Cannizzaro R; Santeufemia DA; Cossu A; Buonadonna A; De Re V
Cancer Biol Ther; 2018 Apr; 19(4):254-259. PubMed ID: 29131691
[TBL] [Abstract][Full Text] [Related]
13. Familial gastric cancer and germline mutations of E-cadherin.
Corso G; Marrelli D; Roviello F
Ann Ital Chir; 2012; 83(3):177-82. PubMed ID: 22595728
[TBL] [Abstract][Full Text] [Related]
14. Hereditary gastric cancer.
Oliveira C; Seruca R; Carneiro F
Best Pract Res Clin Gastroenterol; 2009; 23(2):147-57. PubMed ID: 19414142
[TBL] [Abstract][Full Text] [Related]
15. [Familial gastric cancer: diagnosis, treatment and periodic surveillance].
Kluijt I; Sijmons RH; Hoogerbrugge N; Vasen HF; Cats A
Ned Tijdschr Geneeskd; 2011; 155():A2731. PubMed ID: 21329544
[TBL] [Abstract][Full Text] [Related]
16. Hereditary diffuse CDH1 positive gastric cancer. Prophylactic gastrectomy?
Sánchez Fuentes PA; Vidaña Márquez E; Velasco Albendea FJ
Med Clin (Barc); 2021 Jul; 157(1):46-48. PubMed ID: 32773164
[No Abstract] [Full Text] [Related]
17. E-cadherin germline mutation carriers: clinical management and genetic implications.
Corso G; Figueiredo J; Biffi R; Trentin C; Bonanni B; Feroce I; Serrano D; Cassano E; Annibale B; Melo S; Seruca R; De Lorenzi F; Ferrara F; Piagnerelli R; Roviello F; Galimberti V
Cancer Metastasis Rev; 2014 Dec; 33(4):1081-94. PubMed ID: 25332147
[TBL] [Abstract][Full Text] [Related]
18. Establishing a center of excellence for hereditary diffuse gastric cancer syndrome.
Drake J; Schreiber KC; Lopez R; Fasaye GA; Connolly M; Quezado M; Heller T; Hernandez JM; Davis JL
J Surg Oncol; 2019 May; 119(6):673-674. PubMed ID: 30618047
[No Abstract] [Full Text] [Related]
19. [Genetic background and clinical features of hereditary diffuse gastric cancer].
Vasas P; Bijendra P
Orv Hetil; 2011 Jul; 152(28):1105-9. PubMed ID: 21737393
[TBL] [Abstract][Full Text] [Related]
20. Identification of seven novel germline mutations in the human E-cadherin (CDH1) gene.
More H; Humar B; Weber W; Ward R; Christian A; Lintott C; Graziano F; Ruzzo AM; Acosta E; Boman B; Harlan M; Ferreira P; Seruca R; Suriano G; Guilford P
Hum Mutat; 2007 Feb; 28(2):203. PubMed ID: 17221870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
